Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 10 of 123)
- Relevance
  Sort by

Kidney Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028

 Report
February 2020
160 Pages
Global

From

€13647EUR$14,995USD£11,699GBP

Licensing Deals in Pharmaceuticals 2019-2025

 Report
April 2025
1400 Pages
Global

From

€4546EUR$4,995USD£3,897GBP

Cancer Monoclonal Antibodies Market Report by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033

 Report
February 2025
144 Pages
Global

From

€2729EUR$2,999USD£2,340GBP

Lung Cancer Therapeutics Market 2025-2029

 Report
February 2025
216 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Melanoma Therapeutics Market Size, Share & Trends Analysis Report By Product (Chemotherapy, Immunotherapy), By Drug Type (Branded Drugs, Generic Drugs), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
100 Pages
Global

From

€5415EUR$5,950USD£4,642GBP

Kidney Cancer Therapeutics and Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
140 Pages
Global

From

€4323EUR$4,750USD£3,706GBP

Schizophrenia Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

 Report
April 2025
200 Pages
Global

From

€2266EUR$2,490USD£1,943GBP

Urothelial Carcinoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7235EUR$7,950USD£6,203GBP

NASH Treatment & Therapeutics Market Report 2023-2033

 Report
July 2023
224 Pages
Global

From

€4769EUR$5,423USD£3,950GBP

Ovarian Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Bladder Cancer - Pipeline Insight, 2024

 Clinical Trials
April 2024
230 Pages
Global

From

€2730EUR$3,000USD£2,341GBP

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

 Report
April 2025
196 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2024

 Clinical Trials
April 2024
80 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

 Report
February 2022
84 Pages
Global

From

€1182EUR$1,299USD£1,014GBP

Next-Generation Antibody Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4323EUR$4,750USD£3,706GBP

Targeted Oncology Therapeutics: Lung Cancers

 Report
October 2021
82 Pages
Global

From

€3504EUR$3,850USD£3,004GBP

Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact and Forecasts (2023-2028)

 Report
April 2023
107 Pages
Global

From

€4323EUR$4,750USD£3,706GBP

APAC Ovarian Cancer Diagnostics & Therapeutics Size - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
100 Pages
Asia Pacific

From

€4323EUR$4,750USD£3,706GBP

Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
90 Pages
Middle East, Africa

From

€4323EUR$4,750USD£3,706GBP

2,452 Results (Page 10 of 123)
- 1
- 8
- 9
- 10
- 11
- 12

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.